Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nicotrol TD launch

This article was originally published in The Tan Sheet

Executive Summary

Pharmacia's OTC nicotine transdermal three-step dosing system will launch this fall. Prior one-step Nicotrol patch may or may not be discontinued, firm says. Ad agency BBDO (New York), currently assigned to Rogaine, will handle ad campaign. Pharmacia says ads will focus on Nicotrol's 16-hour use period, which some consumers may prefer over 24-hour period for GlaxoSmithKline's NicoDerm CQ. Company says it has no plans for OTC switch of Nicotrol inhaler, nasal spray. Pharmacia received FDA approval of its NDA for Nicotrol TD March 21 (1"The Tan Sheet" March 25, 2002, p. 3)...
Advertisement
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS093830

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel